Irfan Khan

713 total citations
25 papers, 544 citations indexed

About

Irfan Khan is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Irfan Khan has authored 25 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Organic Chemistry and 3 papers in Epidemiology. Recurrent topics in Irfan Khan's work include Click Chemistry and Applications (6 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Chemical Synthesis and Analysis (3 papers). Irfan Khan is often cited by papers focused on Click Chemistry and Applications (6 papers), Advanced biosensing and bioanalysis techniques (6 papers) and Chemical Synthesis and Analysis (3 papers). Irfan Khan collaborates with scholars based in United States, Pakistan and United Kingdom. Irfan Khan's co-authors include Maksim Royzen, José M. Mejía Oneto, Mehmet V. Yigit, Neil Robertson, Kentaro Hanada, Lorena Sánchez-Felipe, Rebecca L Ambrose, Kouacou V. Konan, Jason M. Mackenzie and Qingxia Han and has published in prestigious journals such as PLoS ONE, Chemical Communications and Journal of Virology.

In The Last Decade

Irfan Khan

21 papers receiving 539 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irfan Khan United States 11 385 272 98 77 41 25 544
Janina Cramer Germany 10 415 1.1× 214 0.8× 129 1.3× 33 0.4× 16 0.4× 13 480
Karuppiah Chockalingam United States 9 299 0.8× 63 0.2× 44 0.4× 64 0.8× 51 1.2× 16 470
Origène Nyanguile United States 13 447 1.2× 115 0.4× 57 0.6× 37 0.5× 143 3.5× 17 739
Chengli Zong United States 18 662 1.7× 306 1.1× 39 0.4× 109 1.4× 34 0.8× 40 850
Shuihong Cheng China 13 301 0.8× 177 0.7× 31 0.3× 50 0.6× 83 2.0× 27 535
Nicholas J. Ede Australia 15 376 1.0× 167 0.6× 83 0.8× 13 0.2× 53 1.3× 31 564
Maia Carnevali United States 8 200 0.5× 83 0.3× 29 0.3× 57 0.7× 15 0.4× 10 358
Ashlesha Deshpande United States 15 266 0.7× 77 0.3× 59 0.6× 42 0.5× 102 2.5× 33 725
Michael A. Gelman United States 6 340 0.9× 189 0.7× 17 0.2× 23 0.3× 25 0.6× 7 490
Tharmala Tharmalingam Ireland 11 675 1.8× 134 0.5× 182 1.9× 67 0.9× 19 0.5× 14 792

Countries citing papers authored by Irfan Khan

Since Specialization
Citations

This map shows the geographic impact of Irfan Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irfan Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irfan Khan more than expected).

Fields of papers citing papers by Irfan Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irfan Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irfan Khan. The network helps show where Irfan Khan may publish in the future.

Co-authorship network of co-authors of Irfan Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Irfan Khan. A scholar is included among the top collaborators of Irfan Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irfan Khan. Irfan Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Khan, Irfan, et al.. (2025). Mechanistic studies on pH-permeability relationships: Impact of the membrane polar headgroup region on pKa. International Journal of Pharmaceutics. 673. 125383–125383.
3.
Khan, Irfan, et al.. (2023). Sulforaphane prevents the reactivation of HIV-1 by suppressing NFκB signaling. Journal of Virus Eradication. 9(3). 100341–100341. 5 indexed citations
4.
Khan, Irfan, et al.. (2022). Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling. Journal of NeuroVirology. 28(2). 305–311. 9 indexed citations
5.
Haruehanroengra, Phensinee, et al.. (2021). Bio-orthogonal chemistry enables solid phase synthesis and HPLC and gel-free purification of long RNA oligonucleotides. Chemical Communications. 57(35). 4263–4266. 12 indexed citations
6.
Haruehanroengra, Phensinee, et al.. (2021). Non‐Chromatographic Purification of Synthetic RNA Using Bio‐Orthogonal Chemistry. Current Protocols. 1(9). e247–e247.
7.
Wu, Kui, et al.. (2020). Switchable Fluorescence of Doxorubicin for Label‐Free Imaging of Bioorthogonal Drug Release. ChemMedChem. 15(11). 988–994. 7 indexed citations
8.
Wu, Kui, et al.. (2019). Bio-orthogonal chemistry-based method for fluorescent labelling of ribosomal RNA in live mammalian cells. Chemical Communications. 55(70). 10456–10459. 5 indexed citations
9.
Czuban, Magdalena, Sangeetha Srinivasan, Nathan A. Yee, et al.. (2018). Bio-Orthogonal Chemistry and Reloadable Biomaterial Enable Local Activation of Antibiotic Prodrugs and Enhance Treatments against Staphylococcus aureus Infections. ACS Central Science. 4(12). 1624–1632. 79 indexed citations
10.
Khan, Irfan, et al.. (2017). Frequency of Multi Drug Resistant Nosocomial Pathogens in Intensive Care Units of a Tertiary Care Hospital in Karachi. Annals of King Edward Medical University. 23(2). 1 indexed citations
11.
Khan, Irfan, et al.. (2017). Controlled in-cell activation of RNA therapeutics using bond-cleaving bio-orthogonal chemistry. Chemical Science. 8(8). 5705–5712. 38 indexed citations
12.
Robertson, Neil, et al.. (2017). Single-trigger dual-responsive nanoparticles for controllable and sequential prodrug activation. Nanoscale. 9(28). 10020–10030. 12 indexed citations
13.
Khan, Irfan, et al.. (2016). Current Pattern of Antibiotic Resistance in Clinical Isolates of Acinetobacter Baumannii from Intensive Care Units of Tertiary Care Hospital. Annals of King Edward Medical University. 22(1). 17–17. 1 indexed citations
14.
Rana, Muhit, Mustafa Balcioglu, Mustafa Salih Hizir, et al.. (2016). Reprogrammable multiplexed detection of circulating oncomiRs using hybridization chain reaction. Chemical Communications. 52(17). 3524–3527. 40 indexed citations
15.
Khan, Irfan, Paul F. Agris, Mehmet V. Yigit, & Maksim Royzen. (2016). In situ activation of a doxorubicin prodrug using imaging-capable nanoparticles. Chemical Communications. 52(36). 6174–6177. 31 indexed citations
16.
Khan, Irfan, et al.. (2015). E05. Infectious Pyomyositis caused by <italic>Staphylococcus Aureus</italic>. Lara D. Veeken. 1 indexed citations
17.
Khan, Irfan, et al.. (2013). Use of the SYBR Green dye for measuring helicase activity. Enzyme and Microbial Technology. 52(3). 196–198. 4 indexed citations
18.
Sharma, Sushil Kumar, et al.. (2013). Minimizing Product Rejection in Small Scale Industries using Six Sigma Approach-A case study. 1 indexed citations
19.
Khan, Irfan, et al.. (2011). Fluoroquinolones Inhibit HCV by Targeting Its Helicase. Antiviral Therapy. 17(3). 467–476. 23 indexed citations
20.
Kassi, Mahwash, et al.. (2010). Safe blood transfusion practices in blood banks of Karachi, Pakistan. Transfusion Medicine. 21(1). 57–62. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026